Vasopressin-binding l-nucleic acid

Details for Australian Patent Application No. 2005311497 (hide)

Owner Noxxon Pharma AG

Inventors Rohl, Ingo; Eulberg, Dirk; Purschke, Werner; Vater, Axel; Klussmann, Sven

Agent Pizzeys

Pub. Number AU-B-2005311497

PCT Pub. Number WO2006/058705

Priority 10 2004 057 523.1 29.11.04 DE

Filing date 29 November 2005

Wipo publication date 8 June 2006

Acceptance publication date 8 March 2012

International Classifications

C12N 15/115 (2010.01) Mutation or genetic engineering - Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith

Event Publications

21 June 2007 PCT application entered the National Phase

  PCT publication WO2006/058705 Priority application(s): WO2006/058705

8 March 2012 Application Accepted

  Published as AU-B-2005311497

7 June 2012 Application for Amendment

  The nature of the amendment is: Amend the name of the inventor to read Roehl, Ingo; Eulberg, Dirk; Purschke, Werner; Vater, Axel and Klussmann, Sven. Address for service in Australia - Pizzeys Patent and Trade Mark Attorneys Level 20 324 Queen Street Brisbane QLD 4000 2006

27 September 2012 Amendment Made

  The nature of the amendment is: Amend the name of the inventor to read Purschke, Werner; Eulberg, Dirk; Klussmann, Sven; Roehl, Ingo and Vater, Axel

4 October 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005311505-Method for delivering hot and cold beverages on demand in a variety of flavorings and nutritional additives

2005311492-Acetamide compounds as fungicides